Eterna Therapeutics Inc.
SEC Filing List
ERNA CIK: 0000748592
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | ELECTRONIC PUBLISHING SERVICES INC /fa | 05/14/2026 | |||
| SCHEDULE 13G | 05/14/2026 | ||||
| SCHEDULE 13G/A | Toppan Merrill/FA | 05/13/2026 | |||
| ARS | Annual report to security holders | Ernexa Therapeutics Inc. | M2 COMPLIANCE LLC /fa | 05/11/2026 | |
| DEF 14A | Definitive proxy statements | Ernexa Therapeutics Inc. | M2 COMPLIANCE LLC /fa | 05/11/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Ernexa Therapeutics Inc. | M2 COMPLIANCE LLC /fa | 05/11/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Ernexa Therapeutics Inc. | M2 COMPLIANCE LLC /fa | 05/11/2026 | |
| 8-K | Current report filing | Ernexa Therapeutics Inc. | M2 COMPLIANCE LLC /fa | 05/04/2026 | |
| DEF 14C | Definitive information statements | Ernexa Therapeutics Inc. | M2 COMPLIANCE LLC /fa | 04/13/2026 | |
| PRE 14C | Preliminary information statement not re... | Ernexa Therapeutics Inc. | M2 COMPLIANCE LLC /fa | 04/01/2026 | |
| No record found. | |||||
| Load More | |||||
